DrugPatentWatch Database Preview

Betrixaban - Generic Drug Details

« Back to Dashboard

What are the generic sources for betrixaban and what is the scope of betrixaban freedom to operate?

Betrixaban is the generic ingredient in one branded drug marketed by Portola Pharms Inc and is included in one NDA. There are ten patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Betrixaban has one hundred and twenty-three patent family members in thirty-one countries.

One supplier is listed for this compound.

Summary for betrixaban

International Patents:	123
US Patents:	10
Tradenames:	1
Applicants:	1
NDAs:	1
Suppliers / Packagers:	1
Bulk Api Vendors:	50
Clinical Trials:	9
Patent Applications:	116
Formulation / Manufacturing:	see details
DailyMed Link:	betrixaban at DailyMed

Pharmacology for betrixaban

Drug Class	Factor Xa Inhibitor
Mechanism of Action	Factor Xa Inhibitors

Synonyms for betrixaban

330942-05-7

4CA-0269

74RWP7W0J9

942B057

AB0027977

AB1008465

ABP000384

AK326145

AKOS005146070

AN-3565

API0007103

BC638590

BCP9000395

BDBM50249298

Benzamide, N-(5-chloro-2-pyridinyl)-2-((4-((dimethylamino)iminomethyl)benzoyl)amino)-5-methoxy-

Betrixaban (USAN)

Betrixaban [USAN:INN]

betrixaban maleate

betrixaban/

Bevyxxa

CHEMBL512351

compound 11 [PMID: 19297154]

CS-2481

D08873

D0J0BU

DB12364

EX-A358

FT-0663094

GTPL9602

HE335649

HY-10268

KB-75507

KS-00000645

MFCD16038040

MolPort-009-682-948

N-(5-Chloro-2-pyridinyl)-2-[[4-[(dimethylamino)iminomethyl]benzoyl]amino]-5-methoxybenzamide

N-(5-chloro-2-pyridyl)-2-[[4-(N,N-dimethylcarbamimidoyl)benzoyl]amino]-5-methoxy-benzamide

N-(5-Chloropyridin-2-yl)-2-((4-(N,N-dimethylcarbamimidoyl)benzoyl)amino)-5- methoxybenzamide

N-(5-chloropyridin-2-yl)-2-({[4-(N,N-dimethylcarbamimidoyl)phenyl]carbonyl}amino)-5-methoxybenzamide

N-(5-chloropyridin-2-yl)-2-(4-(N,N-dimethylcarbamimidoyl)benzamido)-5-methoxybenzamide

N-(5-Chloropyridin-2-yl)-2-[[4-(N,N-dimethylcarbamimidoyl)benzoyl]amino]-5-methoxybenzamide

OR073947

PRT 054021

PRT-054021

PRT054021

QCR-99

SCHEMBL158591

UNII-74RWP7W0J9

VA11998

W9900

ZINC30691754

US Patents and Regulatory Information for betrixaban

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Portola Pharms Inc	BEVYXXA	betrixaban	CAPSULE;ORAL	208383-002	Jun 23, 2017		RX	Yes	Yes				Y
Portola Pharms Inc	BEVYXXA	betrixaban	CAPSULE;ORAL	208383-001	Jun 23, 2017		RX	Yes	No			Y	Y
Portola Pharms Inc	BEVYXXA	betrixaban	CAPSULE;ORAL	208383-001	Jun 23, 2017		RX	Yes	No			Y

International Patents for betrixaban

Country	Document Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	0119788
Germany	60115394
China	102762538